What Happened?
San Diego, CA-based RayzeBio Appointed Ken Song as President and Chief Executive Officer
About the Company
RayzeBio is a biotechnology company focused on improving outcomes for people with cancer by harnessing the power of targeted radioisotopes. With a focus on clinically validated solid tumor targets, RayzeBio is developing novel drug conjugates to deliver potent therapeutic radioisotopes such as Actinium-225, an alpha-emitter. The company is backed by a syndicate of sophisticated healthcare investors and was established in 2020
About the Person
Ken Song is President and Chief Executive Officer at RayzeBio. Previously, Ken held various senior HR leadership roles in the industry.
Info Source
News
Short Profile